Osteonectin-expressing cells in human stomach cancer and their possible clinical significance.

[1]  P. Chambon,et al.  Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genes , 1995, International journal of cancer.

[2]  J. Nesland,et al.  Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma , 1994, Cancer.

[3]  M. Ringuette,et al.  Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer. , 1999, Gynecologic oncology.

[4]  V. Castronovo,et al.  Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. , 1995, The American journal of pathology.

[5]  L. Sobin,et al.  The world health organization's histologic classification of gastrointestinal tumors: A commentary on the second edition , 1990, Cancer.

[6]  C. Stadtländer,et al.  Molecular epidemiology, pathogenesis and prevention of gastric cancer. , 1999, Carcinogenesis.

[7]  T. Ito,et al.  Differentially expressed MHC class II-associated invariant chain in rat stomach pyloric mucosa with N-methyl-N-nitro-nitrosoguanidine exposure. , 1997, Cancer research.

[8]  C. la Vecchia,et al.  Worldwide patterns of cancer mortality, 1990-1994. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[9]  M. Young,et al.  Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane. , 1988, The American journal of pathology.

[10]  H. Yokozaki,et al.  Co‐expression of osteopontin and CD44v9 in gastric cancer , 1998, International journal of cancer.

[11]  R L Vessella,et al.  Differential expression of osteonectin/SPARC during human prostate cancer progression. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  T. Ito,et al.  Involvement of dendritic cell response to resistance of stomach carcinogenesis caused by N-methyl-N'-nitro-N-nitrosoguanidine in rats. , 1998, Cancer research.